3

3

SEC Filing Details

Document Details

Form
Filing Date
Mar 8, 2024
Document Date
Feb 29, 2024
Form Description
Initial filing by director officer or owner of more than ten percent
Filing Group
3,4,5
Company
Y-mAbs Therapeutics, Inc.
Issuer
Y-mAbs Therapeutics, Inc.
Filer
TAGLIAFERRI MARY